Nesfatin-1 was discovered in 2006 and implicated in the regulation of food intake.
Subsequently, its widespread central and peripheral distribution gave rise to additional …

Nesfatin-1 was discovered a decade ago and despite the fact that it represents just one of a
multitude of food intake-inhibiting factors it received increasing attention. This led to a …

Background Since lifestyle changes are main therapies for non-alcoholic fatty liver disease
(NAFLD), changing dietary components (nutritional or bioactive) may play a parallel …

Nesfatin-1, a satiety-inducing peptide identified in hypothalamic regions that regulate energy
balance, is an integral regulator of energy homeostasis and a putative glucose-dependent …

Nesfatin‐1 was discovered in 2006 and introduced as a potential novel anorexigenic
modulator of food intake and body weight. The past years have witnessed increasing …

The recently discovered nesfatin-1 is regulated by hunger and satiety. The precursor protein
NUCB2 is proteolytically cleaved into three resulting fragments: nesfatin-1, nesfatin-2, and …

Nonalcoholic fatty liver disease (NAFLD), also recently referred as metabolic (dysfunction)-
associated fatty liver disease (MAFLD), is characterized by hepatocyte steatosis in the …

Objective NUCB2/nesfatin-1 is an anorexigenic hormone with elevated levels in obese and
decreased levels in anorexia nervosa (AN) patients. Moreover, a role in the regulation of …

The aim of this study was to characterize the mechanism by which peripheral nesfatin-1
regulates hepatic lipid metabolism. Continuous peripheral infusion of nesfatin-1 reduced …

Nesfatin-1 is cleaved from nucleobindin2 (NUCB2) and implicated in the regulation of
hunger and satiety as anorexigenic peptide hormone. Circulating NUCB2/nesfatin-1 is …